BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25459070)

  • 21. Postmastectomy Radiation Therapy Based on Pathologic Nodal Status in Clinical Node-Positive Stage II to III Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Huang Z; Zhu L; Huang XB; Tang Y; Rong QL; Shi M; Wang WH; Tie J; Shen LF; Chen JY; Zhang J; Wu HF; Cheng J; Liu M; Tan YT; Ma CY; Wang SL; Li YX
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1030-1039. PubMed ID: 32585337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
    Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.
    Wu SG; Sun JY; Zhou J; Li FY; Zhou H; Lin Q; Lin HX; Bao Y; He ZY
    Radiat Oncol; 2014 Dec; 9():284. PubMed ID: 25511525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmastectomy radiation therapy in T3 node-negative breast cancer.
    Elmore L; Deshpande A; Daly M; Margenthaler JA
    J Surg Res; 2015 Nov; 199(1):90-6. PubMed ID: 25976852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy.
    Xin F; Yu Y; Yang ZJ; Hou LK; Mao JF; Xia L; Wang X; Cao XC
    Tumour Biol; 2016 Jun; 37(6):8445-54. PubMed ID: 26733172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: A prelude to NSABP B-51?
    Haque W; Singh A; Verma V; Schwartz MR; Chevli N; Hatch S; Desai M; Butler EB; Arentz C; Farach A; Teh BS
    Radiother Oncol; 2021 Sep; 162():52-59. PubMed ID: 34214615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy.
    Kim D; Kim JH; Kim IA; Chang JH; Shin KH
    Cancer Res Treat; 2023 Apr; 55(2):592-602. PubMed ID: 36228653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort.
    Forissier V; Tallet A; Cohen M; Classe JM; Reyal F; Chopin N; Mazouni C; Gimbergues P; Daraï E; Colombo PE; Azuar P; Lambaudie E; Houvenaeghel G
    Eur J Cancer; 2017 Dec; 87():47-57. PubMed ID: 29107861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
    Miyashita M; Niikura N; Kumamaru H; Miyata H; Iwamoto T; Kawai M; Anan K; Hayashi N; Aogi K; Ishida T; Masuoka H; Iijima K; Masuda S; Tsugawa K; Kinoshita T; Tsuda H; Nakamura S; Tokuda Y
    Ann Surg Oncol; 2019 Aug; 26(8):2475-2485. PubMed ID: 31102090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: is there a benefit?
    Yadav BS; Sharma SC; George P; Bansal A
    J Cancer Res Ther; 2014; 10(2):279-83. PubMed ID: 25022378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of postmastectomy radiation therapy in clinically node-positive breast cancerpatients with pathologically negative lymph nodes after neoadjuvant chemotherapy.
    Sayan M; Vergalasova I; George M; Kowzun M; Potdevin L; Kumar S; Haffty B; Ohri N
    Turk J Med Sci; 2022 Apr; 52(2):279-285. PubMed ID: 36161617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.
    Haffty BG; McCall LM; Ballman KV; Buchholz TA; Hunt KK; Boughey JC
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):174-182. PubMed ID: 31085287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
    Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
    BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmastectomy radiation and survival in older women with breast cancer.
    Smith BD; Haffty BG; Hurria A; Galusha DH; Gross CP
    J Clin Oncol; 2006 Oct; 24(30):4901-7. PubMed ID: 17050874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 36. Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy.
    Kantor O; Pesce C; Singh P; Miller M; Tseng J; Wang CH; Winchester DJ; Yao K
    J Surg Oncol; 2017 May; 115(6):668-676. PubMed ID: 28083910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.
    Garg AK; Oh JL; Oswald MJ; Huang E; Strom EA; Perkins GH; Woodward WA; Yu TK; Tereffe W; Meric-Bernstam F; Hahn K; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1478-83. PubMed ID: 17855016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
    Daveau C; Stevens D; Brain E; Berges O; Villette S; Moisson P; Gardner M; De la Lande B; Lasry S; Labib A; Le Scodan R
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):337-42. PubMed ID: 20171795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers.
    Francis SR; Frandsen J; Kokeny KE; Gaffney DK; Poppe MM
    Breast; 2017 Apr; 32():156-161. PubMed ID: 28193571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
    Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
    Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.